Target intelligence / Profile preview

Human metapneumovirus nucleoprotein (hMPV N)

Target
hMPV N
Molecular classification
Viral protein, Nucleocapsid protein, RNA-binding protein
01

Overview

The Human metapneumovirus nucleoprotein (hMPV N) is a critical structural component of the virus, responsible for encapsidating the single-stranded, negative-sense RNA genome. This encapsulation protects the viral RNA from host nucleases and serves as the essential template for both transcription and replication by the viral RNA-dependent RNA polymerase complex. The N protein forms a helical ribonucleoprotein (RNP) complex by interacting with the viral phosphoprotein (P), which acts as a bridge to the large (L) polymerase protein. Because the N protein is highly conserved and indispensable for the viral life cycle, it is a primary target for the development of antiviral therapies and vaccines. Current therapeutic strategies focus on small-molecule inhibitors that disrupt the N-P interaction or prevent N-RNA binding, as well as mRNA-based vaccines designed to elicit robust T-cell and B-cell responses against this internal viral antigen.

Other names
Nucleocapsid proteinN proteinhMPV nucleoproteinProtein N
02

Mechanism of action

Inhibition of viral RNA synthesis by disrupting the formation of the ribonucleoprotein complex or preventing the interaction between the nucleoprotein and the viral polymerase complex (via the phosphoprotein).

03

Biological functions

Viral replicationRNA encapsulationViral transcriptionGenome packagingInteraction with phosphoprotein (P)Formation of the ribonucleoprotein (RNP) complex
04

Disease associations

InfectionRespiratory tract infectionBronchiolitisPneumonia
05

Safety considerations

Viral resistance through mutationsPotential for vaccine-enhanced respiratory disease (ERD)High sequence conservation may limit drug specificity across different viral strains
06

Interacting drugs

mRNA-1653 (Vaccine candidate)

2 more in the full profile.

07

Biomarkers

hMPV RNA levelsAnti-N antibodiesViral load in respiratory secretions

Beyond the preview

Go deeper on Human metapneumovirus nucleoprotein (hMPV N).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human metapneumovirus nucleoprotein (hMPV N).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call